Error: Could not add to watchlist. X
+ Watchlist

Candriam Equities L Biotechnology

DEXEBTD:LX
481.36
USD
0.27
0.06%
As of 12:59 AM EDT 5/23/2017
Fund Type
SICAV
52Wk Range
376.42 - 498.18
1 Yr Return
12.95%
YTD Return
13.49%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
481.09
52Wk Range
376.42 - 498.18
1 Yr Return
15.95%
YTD Return
13.49%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 05/23/2017)
481.36
Total Assets (m USD) (on 05/23/2017)
676.862
Inception Date
04/06/2000
Last Dividend (on 04/25/2017)
2.5
Dividend Indicated Gross Yield
0.52%
Fund Managers
RUDI VAN DEN EYNDE
Front Load Fee
3.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.50%
Expense Ratio
1.81%

Top Fund Holdings

Name Position Value % of Fund
126.80 k 49.14 m 7.64
689.00 k 46.80 m 7.28
291.00 k 38.90 m 6.05
136.75 k 37.39 m 5.82
294.00 k 36.58 m 5.69
217.70 k 35.72 m 5.56
192.00 k 21.00 m 3.27
166.50 k 20.19 m 3.14
100.00 k 15.39 m 2.39
158.00 k 13.87 m 2.16
Profile
Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
Address
Candriam Luxembourg
Serenity - Bloc B, 19-21
19-21 route d'Arlon
L-8009 Strasseb - Luxembourg
Phone
352-2797-1